Product Code: GVR-1-68038-718-6
Immunohistochemistry Market Growth & Trends:
The global immunohistochemistry market size is expected to reach USD 3.92 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to register a CAGR of 8.4% during the forecast period. The high demand for accurate data has driven several technological advancements in IHC techniques, resulting in the delivery of precise and contextual data analyses. The emergence of advanced techniques, such as multiplex IHC, computational pathology, and next-generation IHC, is driving the global market. Immunohistochemistry protocols have gained popularity in clinical pathology, especially in the subspecialties of oncologic pathology, hematopathology, and neuropathology.
The technique has played a vital role in shaping cancer diagnostics. Thus, the growing prevalence of cancer is expected to increase the demand for IHC, thus contributing to market growth. Furthermore, the wide application scope of IHC in drug discovery and development activities is expected to boost revenue growth over the forecast period. Whole slide imaging and digital image analysis offer highly accurate and objective evaluations. Thus, image analysis can be used across different aspects of drug discovery including drug repositioning, target validation, patient stratification, biomarker expression studies, and drug efficacy & safety studies.
Acknowledging the profitable opportunities posed by the space, operating players in the industry continue to undertake strategic initiatives to strengthen their market presence. For instance, in June 2021, PathAI, in collaboration with AstraZeneca and Daiichi Sankyo Company Ltd., created machine learning-based models to enable automated quantification of HER2 IHC images in breast cancer samples. The global market will benefit from the growing geriatric population in developed and developing nations. As the global geriatric population increases, the prevalence of age-related illnesses is predicted to rise drastically.
Immunohistochemistry Market Report Highlights:
- The antibodies product segment led the market in 2021 owing to the high use of antibodies for immunohistochemistry assays carried out for disease diagnosis and drug testing workflows
- The diagnostics application segment led the market in 2021 owing to the widespread application of IHC tests in diagnostic settings
- The drug testing segment is expected to witness significant growth during the forecast period. This is due to increasing investment flow by pharmaceutical companies in R&D activities of novel drug discovery and development
- The hospitals and diagnostic laboratories end-use segment accounted for the largest revenue share in 2021. Research institutes are expected to register the fastest CAGR over the forecast period owing to the increasing adoption of IHC in research institutes for drug discovery activities
- North America emerged as the largest regional market in 2021 owing to the confluence of multiple factors, such as high cancer prevalence, presence of key players, and developed healthcare & biotechnological sectors
- The Asia Pacific is projected to grow at the fastest CAGR over the forecast period with China being the fastest-growing market. Increasing regulatory approvals and the launch of novel IHC solutions in China are accelerating the country's market growth
- Key players are engaged in making focused attempts to reinforce their market position and gain a competitive advantage
Table of Contents
Chapter 1. Methodology And Scope
- 1.1 Research Assumptions
- 1.2 Research Methodology
- 1.2.1 Estimates And Forecast Timeline
- 1.3 Research Methodology
- 1.4 Information Procurement
- 1.4.1 Purchased Database
- 1.4.2 GVR's Internal Database
- 1.4.3 Secondary Sources
- 1.4.4 Primary Research
- 1.4.4.1 Market players
- 1.4.4.2 Secondary Data Sources
- 1.5 Information or Data Analysis
- 1.5.1 Data Analysis Models
- 1.6 Market Formulation and Validation
- 1.7 Market Model
- 1.7.1 Model Details
- 1.7.1.1 Research Approach
- 1.7.2 Revenue Share Assessment Of Technology Scope
- 1.8 Objectives
- 1.8.1 Objective 1
- 1.8.2 Objective 2
Chapter 2. Executive Summary
- 2.1 Market Summary, 2021
- 2.2 Market Segmentation
Chapter 3. Immunohistochemistry Market Variables, Trends, & Scope
- 3.1 Market Lineage Outlook
- 3.1.1 Parent Market Outlook
- 3.1.2 Related/Ancillary Market Outlook
- 3.2 Market Dynamics
- 3.2.1 Market Driver Analysis
- 3.2.1.1 Emergence of multiplexed immunohistochemistry
- 3.2.1.2 Implementation of automation and machine learning in IHC
- 3.2.1.3 Increase in prevalence of cancer
- 3.2.2 Market Restraint Analysis
- 3.2.2.1 High instrument cost
- 3.2.2.2 Limitations associated with IHC techniques
- 3.2.3 Industry Challenges
- 3.2.3.1 Quality assurance and standardization related challenges
- 3.2.3.2 Limited scope for multiple evaluations
- 3.3 COVID-19 Impact Analysis
- 3.4 Immunohistochemistry Market: Market Analysis Tools
- 3.4.1 Industry Analysis - Porter's
- 3.4.2 SWOT Analysis, By Factor (Political & Legal, Economic, And Technological)
- 3.4.3 Regulatory Framework
- 3.5 Penetration and Growth Prospect Mapping for Product, 2021
Chapter 4. Competitive Landscape
- 4.1 Recent Developments & Impact Analysis, by Key Market Participants
- 4.2 Company Categorization
- 4.3 Private Companies
- 4.3.1 List Of Key Private Companies
- 4.3.2 Strategy Framework Analysis
- 4.4 Stakeholders Landscape
- 4.4.1 List Of Key End Users, Suppliers, And Competitors
- 4.5 Major Deals & Strategic Alliances Analysis
- 4.5.1 Mergers & Acquisitions
- 4.5.2 Licensing & Partnership
- 4.5.3 Technology Collaborations
- 4.6 Regional Network Map
Chapter 5. Immunohistochemistry Market: Product Business Analysis
- 5.1 Immunohistochemistry Market: Product Movement Analysis
- 5.2 Antibodies
- 5.2.1 Primary Antibodies
- 5.2.1.1 Immunohistochemistry Primary Antibodies Market Estimates And Forecast 2018 - 2030 (USD Million)
- 5.2.2 Secondary Antibodies
- 5.2.1.1 Immunohistochemistry Secondary Antibodies Market Estimates And Forecast 2018 - 2030 (USD Million)
- 5.3 Equipment
- 5.3.1 Slide Staining Systems
- 5.3.1.1 Immunohistochemistry Slide Staining Systems Market Estimates And Forecast 2018 - 2030 (USD Million)
- 5.3.2. Tissue Microarrays
- 5.3.2.1 Immunohistochemistry Tissue Microarrays Market Estimates And Forecast 2018 - 2030 (USD Million)
- 5.3.3. Tissue Processing Systems
- 5.3.3.1 Immunohistochemistry Tissue Processing Systems Market Estimates And Forecast 2018 - 2030 (USD Million)
- 5.3.4. Slide Scanners
- 5.3.4.1 Immunohistochemistry Slide Scanners Market Estimates And Forecast 2018 - 2030 (USD Million)
- 5.3.5. Others
- 5.3.5.1 Others Immunohistochemistry Market Estimates And Forecast 2018 - 2030 (USD Million)
- 5.4. Reagents
- 5.4.1 Histological Stains
- 5.4.1.1 Immunohistochemistry Histological Stains Market Estimates And Forecast 2018 - 2030 (USD Million)
- 5.4.2. Blocking Sera And Reagents
- 5.4.2.1 Immunohistochemistry Blocking Sera and Reagents Market Estimates And Forecast 2018 - 2030 (USD Million)
- 5.4.3. Chromogenic Substrates
- 5.4.3.1 Immunohistochemistry Chromogenic Substrates Market Estimates And Forecast 2018 - 2030 (USD Million)
- 5.4.4. Fixation Reagents
- 5.4.4.1 Immunohistochemistry Fixation Reagents Market Estimates And Forecast 2018 - 2030 (USD Million)
- 5.4.5. Stabilizers
- 5.4.5.1 Immunohistochemistry Stabilizers Market Estimates And Forecast 2018 - 2030 (USD Million)
- 5.4.6. Organic Solvents
- 5.4.6.1 Immunohistochemistry Organic Solvents Market Estimates And Forecast 2018 - 2030 (USD Million)
- 5.4.7. Proteolytic Enzymes
- 5.4.7.1 Immunohistochemistry Proteolytic Enzymes Market Estimates And Forecast 2018 - 2030 (USD Million)
- 5.4.8. Diluents
- 5.4.8.1 Immunohistochemistry Diluents Market Estimates And Forecast 2018 - 2030 (USD Million)
- 5.5. Kits
- 5.5.1. Immunohistochemistry Kits Market Estimates And Forecast 2018 - 2030 (USD Million)
Chapter 6. Immunohistochemistry Market: Application Business Analysis
- 6.1 Global Immunohistochemistry Market: Application Movement Analysis
- 6.2 Diagnostics
- 6.2.1 Cancer
- 6.2.1.1 Immunohistochemistry Cancer Market Estimates And Forecast 2018 - 2030 (USD Million)
- 6.2.2 Infectious Diseases
- 6.2.2.1 Immunohistochemistry Infectious Diseases Market Estimates And Forecast 2018 - 2030 (USD Million)
- 6.2.3 Cardiovascular Diseases
- 6.2.3.1 Immunohistochemistry Cardiovascular Diseases Market Estimates And Forecast 2018 - 2030 (USD Million)
- 6.2.4 Autoimmune Diseases
- 6.2.4.1 Immunohistochemistry Autoimmune Diseases Market Estimates And Forecast 2018 - 2030 (USD Million)
- 6.2.5 Diabetes Mellitus
- 6.2.5.1 Immunohistochemistry Diabetes Mellitus Market Estimates And Forecast 2018 - 2030 (USD Million)
- 6.2.6 Nephrological Diseases
- 6.2.6.1 Immunohistochemistry Nephrological Diseases Market Estimates And Forecast 2018 - 2030 (USD Million)
- 6.3 Drug Testing
- 6.3.1. Immunohistochemistry Drug Testing Market Estimates And Forecast 2018 - 2030 (USD Million)
Chapter 7. Immunohistochemistry Market: End-use Business Analysis
- 7.1 Immunohistochemistry Market: End-use Movement Analysis
- 7.2 Hospitals & Diagnostic Laboratories
- 7.2.1 Immunohistochemistry Hospitals & Diagnostic Laboratories Market Estimates And Forecast, 2017-2028 (USD Million)
- 7.3 Research Institutes
- 7.3.1 Immunohistochemistry Research Institutes Market Estimates And Forecast, 2017-2028 (USD Million)
- 7.4 Others
- 7.4.1 Others Immunohistochemistry Market Estimates And Forecast 2018 - 2030 (USD Million)
Chapter 8. Immunohistochemistry Market: Regional Business Analysis
- 8.1 Immunohistochemistry: Regional Movement Analysis
- 8.2 North America
- 8.2.1 U.S.
- 8.2.1.1 U.S. Immunohistochemistry Market, By Product 2018 - 2030 (USD Million)
- 8.2.1.2 U.S. Immunohistochemistry market, by application 2018 - 2030 (USD Million)
- 8.2.1.3 U.S. Immunohistochemistry market, By End-use 2018 - 2030 (USD Million)
- 8.2.2 Canada
- 8.2.2.1 Canada Immunohistochemistry Market, By Product 2018 - 2030 (USD Million)
- 8.2.2.2 Canada Immunohistochemistry market, by application 2018 - 2030 (USD Million)
- 8.2.2.3 Canada Immunohistochemistry market, By End-use 2018 - 2030 (USD Million)
- 8.3 Europe
- 8.3.1 Germany
- 8.3.1.1 Germany Immunohistochemistry Market, By Product 2018 - 2030 (USD Million)
- 8.3.1.2 Germany Immunohistochemistry market, by application 2018 - 2030 (USD Million)
- 8.3.1.3 Germany Immunohistochemistry market, By End-use 2018 - 2030 (USD Million)
- 8.3.2 U.K.
- 8.3.2.1 U.K. Immunohistochemistry Market, By Product 2018 - 2030 (USD Million)
- 8.3.2.2 U.K. Immunohistochemistry market, by application 2018 - 2030 (USD Million)
- 8.3.2.3 U.K. Immunohistochemistry market, By End-use 2018 - 2030 (USD Million)
- 8.3.3 France
- 8.3.3.1 France Immunohistochemistry Market, By Product 2018 - 2030 (USD Million)
- 8.3.3.2 France Immunohistochemistry market, by application 2018 - 2030 (USD Million)
- 8.3.3.3 France Immunohistochemistry market, By End-use 2018 - 2030 (USD Million)
- 8.3.4 Italy
- 8.3.4.1 Italy Immunohistochemistry Market, By Product 2018 - 2030 (USD Million)
- 8.3.4.2 Italy Immunohistochemistry market, by application 2018 - 2030 (USD Million)
- 8.3.4.3 Italy Immunohistochemistry market, By End-use 2018 - 2030 (USD Million)
- 8.3.5 Spain
- 8.3.5.1 Spain Immunohistochemistry Market, By Product 2018 - 2030 (USD Million)
- 8.3.5.2 Spain Immunohistochemistry market, by application 2018 - 2030 (USD Million)
- 8.3.5.3 Spain Immunohistochemistry market, By End-use 2018 - 2030 (USD Million)
- 8.3.6 Russia
- 8.3.6.1 Russia Immunohistochemistry Market, By Product 2018 - 2030 (USD Million)
- 8.3.6.2 Russia Immunohistochemistry market, by application 2018 - 2030 (USD Million)
- 8.3.6.2 Russia Immunohistochemistry market, By End-use 2018 - 2030 (USD Million)
- 8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.1.1 Japan Immunohistochemistry Market, By Product 2018 - 2030 (USD Million)
- 8.4.1.2 Japan Immunohistochemistry market, by application 2018 - 2030 (USD Million)
- 8.4.1.3 Japan Immunohistochemistry market, By End-use 2018 - 2030 (USD Million)
- 8.4.2 China
- 8.4.2.1 China Immunohistochemistry Market, By Product 2018 - 2030 (USD Million)
- 8.4.2.2 China Immunohistochemistry market, by application 2018 - 2030 (USD Million)
- 8.4.2.3 China Immunohistochemistry market, By End-use 2018 - 2030 (USD Million)
- 8.4.3 India
- 8.4.3.1 India Immunohistochemistry Market, By Product 2018 - 2030 (USD Million)
- 8.4.3.2 India Immunohistochemistry market, by application 2018 - 2030 (USD Million)
- 8.4.3.3 India Immunohistochemistry market, By End-use 2018 - 2030 (USD Million)
- 8.4.4 Australia
- 8.4.4.1 Australia Immunohistochemistry Market, By Product 2018 - 2030 (USD Million)
- 8.4.4.2 Australia Immunohistochemistry market, by application 2018 - 2030 (USD Million)
- 8.4.4.3 Australia Immunohistochemistry market, By End-use 2018 - 2030 (USD Million)
- 8.4.5 Singapore
- 8.4.5.1 Singapore Immunohistochemistry Market, By Product 2018 - 2030 (USD Million)
- 8.4.5.2 Singapore Immunohistochemistry market, by application 2018 - 2030 (USD Million)
- 8.4.5.3 Singapore Immunohistochemistry market, By End-use 2018 - 2030 (USD Million)
- 8.4.6 South Korea
- 8.4.6.1 South Korea Immunohistochemistry Market, By Product 2018 - 2030 (USD Million)
- 8.4.6.2 South Korea Immunohistochemistry market, by application 2018 - 2030 (USD Million)
- 8.4.6.3 South Korea Immunohistochemistry market, By End-use 2018 - 2030 (USD Million)
- 8.5 Latin America
- 8.5.1 Brazil
- 8.5.1.1 Brazil Immunohistochemistry Market, By Product 2018 - 2030 (USD Million)
- 8.5.1.2 Brazil Immunohistochemistry market, by application 2018 - 2030 (USD Million)
- 8.5.1.3 Brazil Immunohistochemistry market, By End-use 2018 - 2030 (USD Million)
- 8.5.2 Mexico
- 8.5.2.1 Mexico Immunohistochemistry Market, By Product 2018 - 2030 (USD Million)
- 8.5.2.2 Mexico Immunohistochemistry market, by application 2018 - 2030 (USD Million)
- 8.5.2.3 Mexico Immunohistochemistry market, By End-use 2018 - 2030 (USD Million)
- 8.5.3 Argentina
- 8.5.3.1 Argentina Immunohistochemistry Market, By Product 2018 - 2030 (USD Million)
- 8.5.3.2 Argentina Immunohistochemistry market, by application 2018 - 2030 (USD Million)
- 8.5.3.3 Argentina Immunohistochemistry market, By End-use 2018 - 2030 (USD Million)
- 8.6 Middle East and Africa
- 8.6.1 South Africa
- 8.6.1.1 South Africa Immunohistochemistry Market, By product 2018 - 2030 (USD Million)
- 8.6.1.2 South Africa Immunohistochemistry market, by application 2018 - 2030 (USD Million)
- 8.6.1.3 South Africa Immunohistochemistry market, By End-use 2018 - 2030 (USD Million)
- 8.6.2 Saudi Arabia
- 8.6.2.1 Saudi Arabia Immunohistochemistry Market, By Product 2018 - 2030 (USD Million)
- 8.6.2.2 Saudi Arabia Immunohistochemistry market, by application 2018 - 2030 (USD Million)
- 8.6.2.3 Saudi Arabia Immunohistochemistry market, By End-use 2018 - 2030 (USD Million)
- 8.6.3 UAE
- 8.6.3.1 UAE Immunohistochemistry Market, By Product 2018 - 2030 (USD Million)
- 8.6.3.2 UAE Immunohistochemistry market, by application 2018 - 2030 (USD Million)
- 8.6.3.3 UAE Immunohistochemistry market, By End-use 2018 - 2030 (USD Million)
Chapter 9. Competitive Profiling
- 9.1 Competitive Profiling
- 9.1.1 Thermo Fisher Scientific Inc.
- 9.1.1.1 Company Overview
- 9.1.1.2 Financial Performance
- 9.1.1.3 Product Benchmarking
- 9.1.1.4 Strategic Initiatives
- 9.1.2 F.Hoffmann-La Roche Ltd.
- 9.1.2.1 Company Overview
- 9.1.2.2 Financial Performance
- 9.1.2.3 Product Benchmarking
- 9.1.2.4 Strategic Initiatives
- 9.1.3 Merck KGaA
- 9.1.3.1Company Overview
- 9.1.3.1 Financial Performance
- 9.1.3.2 Product Benchmarking
- 9.1.3.3 Strategic Initiatives
- 9.1.4 Danaher Corporation
- 9.1.4.1 Company Overview
- 9.1.4.2 Financial Performance
- 9.1.4.3 Product Benchmarking
- 9.1.4.4 Strategic Initiatives
- 9.1.5 Perkinelmer, Inc.
- 9.1.5.1 Company Overview
- 9.1.5.2 Financial Performance
- 9.1.5.3 Product Benchmarking
- 9.1.5.4 Strategic Initiatives
- 9.1.6 Bio-Rad Laboratories, Inc.
- 9.1.6.1 Company Overview
- 9.1.6.2 Financial Performance
- 9.1.6.3 Product Benchmarking
- 9.1.7 Cell Signaling Technology Inc.
- 9.1.7.1 Company Overview
- 9.1.7.2 Product Benchmarking
- 9.1.7.3 Strategic Initiatives
- 9.1.8 Bio SB
- 9.1.8.1 Company Overview
- 9.1.8.2 Product Benchmarking
- 9.1.8.3 Strategic Initiatives
- 9.1.9 Agilent Technologies, Inc.
- 9.1.9.1 Company Overview
- 9.1.9.2 Financial Performance
- 9.1.9.3 Product Benchmarking
- 9.1.9.4 Strategic Initiatives
- 9.1.10 Abcam Plc.
- 9.1.10.1 Company Overview
- 9.1.10.2 Financial Performance
- 9.1.10.3 Product Benchmarking
- 9.1.10.4 Strategic Initiatives